Signet Healthcare Partners logo

Signet Healthcare Partners

North America, New York, United States, New York

Description

Based in New York, U.S., Signet Healthcare Partners aims to invest in commercial-stage companies in the healthcare industry.

Investor Profile

Signet Healthcare Partners has made 19 investments, with 2 in the past 12 months and 53% as lead.

Stage Focus

  • Series Unknown (32%)
  • Series B (21%)
  • Private Equity (16%)
  • Series C (16%)
  • Series D (11%)
  • Series A (5%)

Country Focus

  • United States (63%)
  • Germany (16%)
  • Norway (5%)
  • Australia (5%)
  • The Netherlands (5%)
  • Switzerland (5%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Manufacturing
  • Medical
  • Medical Device
  • Life Science
  • Genetics
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Signet Healthcare Partners frequently co-invest with?

TVM Capital
Europe, Bayern, Germany, Munich
Co-Investments: 2
AC
North America, Florida, United States, Boca Raton
Co-Investments: 1
TVM Capital Life Science
Europe, Bayern, Germany, Munich
Co-Investments: 2
TB
North America, Massachusetts, United States, Boston
Co-Investments: 1
C
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 2
AH
North America, Delaware, United States, Dover
Co-Investments: 1
Pharmascience
North America, Quebec, Canada, Montréal
Co-Investments: 2
Arsenal Capital Management
North America, Missouri, United States, Saint Louis
Co-Investments: 1
JW Asset Management
North America, New York, United States, New York
Co-Investments: 1
AC
Oceania, New South Wales, Australia, Sydney
Co-Investments: 2

What are some of recent deals done by Signet Healthcare Partners?

NorthX Biologics

Matfors, Vasternorrlands Lan, Sweden

NorthX Biologics offer services and support in the development and manufacturing of biologics.

Private EquityMay 14, 2025
leon nanodrugs

München, Bayern, Germany

leon-nanodrugs is a nanotechnology-based drug development company.

BiotechnologyHealth CareMedicalPharmaceutical
Series DAug 6, 2024
Curida

Elverum, Hedmark, Norway

Curida is a pharmaceutical contract development and manufacturing organization (CDMO) with core competence on Blow-Fill-Seal.

BiotechnologyManufacturingPharmaceutical
Private EquityApr 15, 2024
Paragonix Technologies

Cambridge, Massachusetts, United States

Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.

BiotechnologyHealth CareMedical Device
Series BMar 7, 2023
Amount Raised: $24,000,000
Juno Pharmaceuticals

Cremorne, New South Wales, Australia

Juno Pharmaceuticals produces and distributes amoxicillin, hydrochloride syringes, hydromorphone solutions, phentermine tablets & capsules.

ManufacturingMedicalMedical DevicePharmaceuticalRetail
Private EquityFeb 24, 2022
Ascendia Pharmaceuticals

North Brunswick, New Jersey, United States

Ascendia Pharmaceuticals offers a comprehensive suite of pre-formulation for preclinical- and clinical-stage drug candidates.

BiotechnologyHealth CarePharmaceutical
Series UnknownApr 8, 2021
Leading Pharma

Fairfield, New Jersey, United States

A Airfield, NJ based generic pharmaceutical company .

Emergency MedicineHealth CareManufacturingPharmaceutical
Series UnknownJan 8, 2018
Amount Raised: $40,000,000
TELA Bio

Malvern, Pennsylvania, United States

TELA Bio is a life science company that specializes in soft tissue reconstruction.

BiotechnologyLife SciencePharmaceutical
Series UnknownOct 30, 2017
Amount Raised: $25,000,000
Pharmaceutics International

Hunt Valley, Maryland, United States

Pharmaceutics International operates as a science-driven contract development and manufacturing company.

Clinical TrialsHealth CareManufacturingPharmaceutical
Private EquitySep 6, 2016
Amount Raised: $93,000,000
leon nanodrugs

München, Bayern, Germany

leon-nanodrugs is a nanotechnology-based drug development company.

BiotechnologyHealth CareMedicalPharmaceutical
Series AJul 27, 2015
Amount Raised: $20,513,571